REMICADE (infliximab) Biologic Treatment
Links shared publicly online about this topic.
- 1,222total visits
REMICADE (infliximab) Biologic Treatment
View full resource at remicade.com
Tags: Crohn's Disease Medication, Ulcerative Colitis Medication, Rheumatoid Arthritis Medication, Disease and Condition, Remicade
Most Recently Shared on April 22, 2010 at 4:07 pm By:
Remicade is a biologic treatment that has been used to treat more than 1 million people worldwide. Is it right for you?http://bit.ly/b6MHk0
Remicade: first biological agent for paediatric ulcerative colitis | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on May 2, 2012 at 8:57 am By:
Remicade (infliximab): first biological agent licensed for paediatric ulcerative colitis: http://t.co/J4o7OTzh #gastroenterology
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 9:30 am By:
Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis
medicalnewstoday.com — “Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2011 at 8:05 am By:
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis: Janssen Biotech, ... http://t.co/maXFag05
FDA Panel Backs Remicade for Kids With Ulcerative Colitis - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at qualitypointtech.net
Most Recently Shared on July 21, 2011 at 10:45 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisor... http://bit.ly/na9znL
Medical News: FDA Panel Backs Remicade for Kids With Ulcerative Colitis - in Gastroenterology, Inflammatory Bowel Disease from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at medpagetoday.com
Most Recently Shared on July 21, 2011 at 10:16 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis http://bit.ly/q09fHV
Dramatic Response of Nail Psoriasis to Infliximab
hindawi.com — “Nail psoriasis, affecting up to 50% of psoriatic patients, is an important cause of serious psychological and physical distress. Traditional treatments for nail psoriasis, which include topical or intralesional corticosteroids, topical vitamin D analogues, photochemotherapy, oral retinoids, methotrexate, and cyclosporin, can be time-consuming, painful, or limited by significant toxicities. Biological agents may have the potential to revolutionize the management of patients with disabling nail ps” View full resource at hindawi.com
Most Recently Shared on May 12, 2011 at 7:04 am By:
Dramatic Response of Nail Psoriasis to Infliximab: We present another case of disabling nail psoriasis that resp... http://bit.ly/klsSrD
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR
empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA
oncologynurseadvisor.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 10, 2011 at 3:36 pm By:
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients http://goo.gl/fb/qYVQj
Supplemental BLA submitted for Remicade for pediatric ulcerative colitis - MPR
empr.com — “Centocor Ortho Biotech announced that it submitted a supplemental Biologics License Application (sBLA) to the FDA for Remicade (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.” View full resource at empr.com
Most Recently Shared on December 29, 2010 at 4:14 pm By:
MPR News: Supplemental BLA submitted for Remicade for pediatric ulcerative colitis: Centocor Ortho Biotech annou... http://bit.ly/erEMRU
Study shows Remicade can clear psoriasis even after patients fail on other biologic | Psoriasis Cure Now!
psoriasis-cure-now.org — “A study of Remicade (infliximab) in patients who had already failed to respond adequately to a similar biologic showed that Remicade was still often successful” View full resource at psoriasis-cure-now.org
Most Recently Shared on August 2, 2010 at 10:39 pm By:
Study shows Remicade can clear psoriasis even after patients fail on other biologic http://is.gd/dZ3VI
Healthcare Professionals - Ankylosing Spondylitis ASSERT Data
remicade.com — “FDA's acceptance of a Supplemental Biologics License application for treating ankylosing spondylitis with REMICADE" (infliximab) in the U.S. was primarily based on results from ASSERT.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 4:14 am By:
An overview of the ASSERT study involving Remicade and ankylosing spondylitis for health care professionals. http://bit.ly/bHI553
REMICADE (infliximab) and AS ? ASSERT Study
remicade.com — “Approval of REMICADE in the treatment of ankylosing spondylitis was based on the results of the landmark ASSERT study.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 4:10 am By:
ASSERT study shows Remicade improves signs and symptoms in patients with ankylosing spondylitis. Read about it. http://bit.ly/bX6IDl
Pediatric Crohn's Clinical Study
remicade.com — “Read the clinical study about REMICADE" (infliximab) for pediatric Crohn's disease.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 4:08 am By:
It is important that pediatric Crohn's patients receive effective treatment as early as possible. How Remicade can help.http://bit.ly/am8SCM
Lives Changed by REMICADE (infliximab) - Toni's Story (Whole)
remicade.com — “Read the full story about a Crohn's patient named Toni and how she struggled with the side effects of steroid treatment until she found REMICADE" (infliximab).” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 4:00 am By:
Toni felt her Crohn's symptoms were keeping her from being a good mom. See how Remicade has changed her life. http://bit.ly/cpjHHn
Crohn's Disease - Educational and Informational Materials
remicade.com — “Resources providing information on Crohn's disease and its treatment with REMICADE" (infliximab).” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:59 am By:
Crohn's disease patients can find educational and informational material about their condition on the Remicade website. http://bit.ly/dwBVNG
Advertisement

